These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19407316)

  • 41. M1761K mutation in the von Willebrand factor A3 domain associated with impaired collagen binding and without platelet dysfunction.
    Ong DM; Aumann H; Andrews RK; Gardiner EE; Rodgers SE; Davis AK
    Haemophilia; 2016 Jul; 22(4):e345-6. PubMed ID: 27354327
    [No Abstract]   [Full Text] [Related]  

  • 42. Laboratory diagnosis of von Willebrand disease.
    Roberts JC; Flood VH
    Int J Lab Hematol; 2015 May; 37 Suppl 1(Suppl 1):11-7. PubMed ID: 25976955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
    Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
    Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laboratory diagnosis of von Willebrand's disease.
    Rick ME
    Clin Lab Med; 1994 Dec; 14(4):781-94. PubMed ID: 7874871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic testing for von Willebrand disease: the Canadian experience.
    James P; Lillicrap D
    Semin Thromb Hemost; 2006 Jul; 32(5):546-52. PubMed ID: 16862529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. von Willebrand factor propeptide: biology and clinical utility.
    Haberichter SL
    Blood; 2015 Oct; 126(15):1753-61. PubMed ID: 26215113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
    Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
    Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New advances in the diagnosis of von Willebrand disease.
    Sharma R; Haberichter SL
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):596-600. PubMed ID: 31808831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification.
    Hashemi Soteh SM; Anson J; Inbal A; Peake IR; Goodeve AC
    Haemophilia; 2008 May; 14(3):621-4. PubMed ID: 18384353
    [No Abstract]   [Full Text] [Related]  

  • 51. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein.
    Schneppenheim R; Budde U
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():209-15. PubMed ID: 21781257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies.
    Castaman G; Platè M; Giacomelli SH; Rodeghiero F; Duga S
    J Thromb Haemost; 2010 Dec; 8(12):2736-42. PubMed ID: 20854374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease.
    Enayat S; Ravanbod S; Rassoulzadegan M; Jazebi M; Tarighat S; Ala F; Emsley J; Othman M
    Thromb Haemost; 2012 Nov; 108(5):946-54. PubMed ID: 23014764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
    Rodeghiero F; Castaman G; Tosetto A
    Hematology Am Soc Hematol Educ Program; 2009; ():113-23. PubMed ID: 20008189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
    Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
    Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The value of genetic testing for type 2B Von Willebrand disease.
    Roland K; Rapson D; Lillicrap D; James P
    Clin Lab Haematol; 2006 Feb; 28(1):17-21. PubMed ID: 16430455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
    Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
    Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. von Willebrand Disease in Pediatrics: Evaluation and Management.
    O'Brien SH; Saini S
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):425-438. PubMed ID: 31030811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
    Federici AB; Bucciarelli P; Castaman G; Baronciani L; Canciani MT; Mazzucconi MG; Morfini M; Rocino A; Schiavoni M; Oliovecchio E; Iorio A; Mannucci PM
    Semin Thromb Hemost; 2011 Jul; 37(5):511-21. PubMed ID: 22102194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.